BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18780974)

  • 41. Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease.
    Coleman PD; Kazee AM; Lapham L; Eskin T; Rogers K
    Neurobiol Aging; 1992; 13(6):631-9. PubMed ID: 1283445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of A-kinase anchoring protein 79/150-cAMP-dependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin.
    Gomez LL; Alam S; Smith KE; Horne E; Dell'Acqua ML
    J Neurosci; 2002 Aug; 22(16):7027-44. PubMed ID: 12177200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease.
    Yao PJ; Zhu M; Pyun EI; Brooks AI; Therianos S; Meyers VE; Coleman PD
    Neurobiol Dis; 2003 Mar; 12(2):97-109. PubMed ID: 12667465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration.
    Liu X; Erikson C; Brun A
    Dementia; 1996; 7(3):128-34. PubMed ID: 8740626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
    Morabito MA; Sheng M; Tsai LH
    J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
    Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
    Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of Heroin on DLG4 Expression in Hippocampus, Amygdala and Frontal Cortex of Rats].
    Luo LM; Gong Q; Liu JF; Zhao MQ; Chen DD; Xie YY; Zhu H
    Fa Yi Xue Za Zhi; 2015 Jun; 31(3):185-7, 199. PubMed ID: 26442368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of aberrant sprouting in Alzheimer's disease.
    Masliah E; Mallory M; Hansen L; Alford M; Albright T; DeTeresa R; Terry R; Baudier J; Saitoh T
    Neuron; 1991 May; 6(5):729-39. PubMed ID: 1827266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses.
    Hunt CA; Schenker LJ; Kennedy MB
    J Neurosci; 1996 Feb; 16(4):1380-8. PubMed ID: 8778289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life.
    Aoki C; Sherpa AD
    Adv Exp Med Biol; 2017; 1006():119-139. PubMed ID: 28865018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enrichment of N-methyl-D-aspartate NR1 splice variants and synaptic proteins in rat postsynaptic densities.
    Al-Hallaq RA; Yasuda RP; Wolfe BB
    J Neurochem; 2001 Apr; 77(1):110-9. PubMed ID: 11279267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein markers for Alzheimer disease in the frontal cortex and cerebellum.
    Verdile G; Gnjec A; Miklossy J; Fonte J; Veurink G; Bates K; Kakulas B; Mehta PD; Milward EA; Tan N; Lareu R; Lim D; Dharmarajan A; Martins RN
    Neurology; 2004 Oct; 63(8):1385-92. PubMed ID: 15505153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95.
    Vallejo D; Codocedo JF; Inestrosa NC
    Mol Neurobiol; 2017 Apr; 54(3):1759-1776. PubMed ID: 26884267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.
    Bogdanovic N; Davidsson P; Volkmann I; Winblad B; Blennow K
    J Neural Transm (Vienna); 2000; 107(4):463-78. PubMed ID: 11215757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats.
    Martisova E; Aisa B; Guereñu G; Ramírez MJ
    Curr Alzheimer Res; 2013 May; 10(4):420-32. PubMed ID: 23305081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.
    Louneva N; Cohen JW; Han LY; Talbot K; Wilson RS; Bennett DA; Trojanowski JQ; Arnold SE
    Am J Pathol; 2008 Nov; 173(5):1488-95. PubMed ID: 18818379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
    Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
    Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurochemical dissection of synaptic pathology in Alzheimer's disease.
    Davidsson P; Blennow K
    Int Psychogeriatr; 1998 Mar; 10(1):11-23. PubMed ID: 9629521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.